6,553
Views
36
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial

, , , , , , & show all
Pages 1051-1058 | Received 08 Sep 2016, Accepted 23 Nov 2016, Published online: 21 Feb 2017